<DOC>
	<DOCNO>NCT02807909</DOCNO>
	<brief_summary>The study conduct assess effect co-administration itraconazole diltiazem , respectively , pharmacokinetic ( PK ) parameter Cmax , AUC ( INF ) , AUC ( 0-T ) BMS-986177</brief_summary>
	<brief_title>A Study Evaluate Effect Co-administration Itraconazole Diltiazem Pharmacokinetics BMS-986177 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<criteria>1 . Signed Informed Consent 2 . Target population : Healthy subject determine medical history , surgical history , physical examination , vital sign , electrocardiogram ( ECG ) , clinical laboratory determination . 3 . Subjects body mass index 18 30 kg/m2 , inclusive 4 . Men , woman nonchildbearing potential . Women must document proof childbearing potential breast feed 5 . Males sexually active woman childbearing potential ( WOCBP ) must agree follow instruction method ( ) contraception duration treatment study drug ( ) plus 5 halflives study drug ( 3 day ) plus 90 day ( duration sperm turnover ) total 92 day subject BMS986177 diltiazem sequence , 99 day subject BMS986177 itraconazole sequence . 1 . Any significant acute chronic medical illness , include hepatic disease , condition list contraindication diltiazem itraconazole package insert . 2 . Evidence coagulopathy , prolong unexplained clinically significant bleeding , frequent unexplained bruising thrombus formation . 3 . History chronic constipation , GI disease , arrhythmia , sinus bradycardia , significant head injury , dizziness headache , hemophilia , Rosenthal syndrome , FX1a deficiency coagulopathies , systemic lupus erythematosus . 4 . Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG , clinical laboratory determination beyond consistent target population 5 . History allergy BMS986177 , itraconazole , diltiazem , related compound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>